speb/financial-data huggingface dataset:
Financial ratios for RBBN — annual report dated 2022-12-31
Total revenue: 819760000
Gross profit: 400936000
Operating income: -31205000
Net income: -98083000
Capital expenditures: 10254000
Operating cash flow: -26364000
Depreciation & amortization: 76483000
Net tangible assets: -77193000
Owner earnings: -31854000
Buffett classification: The Gruesome
Stock price: 2.79
Shares outstanding: 176139067
Book value: 518427000
P/B ratio: 0.9479213021891221
Market cap (USD): 491427996.93
Debt to equity: 0.7482769994618336
Current ratio: 1.4462817669360621
Quick ratio: 1.2180681587809727
Interest coverage ratio: -1.577603640040445
COGS to revenue (%): 51.09105103932858
R&D to revenue (%): 24.845808529325655
SG&A to revenue (%): 24.25331804430565
Free cash flow (dilution-adjusted): -58625000
Buyback yield (%): 0
Retained earnings: -1453744000
Inventory turnover: 5.553001073942962
Receivables turnover: 3.0674589513702832
Capitalized R&D asset: 203676000
ROCI (R&D-adjusted, %): 9.26505231021655
FCF margin (%): -7.151483360983703
Rule of 40 score: -7.151483360983703
Financial ratios for RBBN — annual report dated 2023-12-31
Total revenue: 826339000
Gross profit: 408083000
Operating income: -3600000
Net income: -66206000
Capital expenditures: 9381000
Operating cash flow: 17087000
Depreciation & amortization: 70996000
Net tangible assets: -86216000
Owner earnings: -4591000
Buffett classification: The Gruesome
Stock price: 2.9
Shares outstanding: 176139067
Book value: 452763000
P/B ratio: 1.1281913369687895
Market cap (USD): 510803294.3
Debt to equity: 0.6339608139357678
Current ratio: 1.2276492129250922
Quick ratio: 1.00036355853439
Interest coverage ratio: -0.13177159590043924
COGS to revenue (%): 50.615546404078714
R&D to revenue (%): 23.072855087318885
SG&A to revenue (%): 23.286084766663564
Free cash flow (dilution-adjusted): -14200000
Buyback yield (%): 0
Retained earnings: -1519950000
Inventory turnover: 5.3953896363566
Receivables turnover: 3.078518446768323
Capitalized R&D asset: 327122920
ROCI (R&D-adjusted, %): 4.920768269353496
Rosenberg metric: 0.035090044973389106
FCF margin (%): -1.718423068498522
Revenue growth (%): 0.8025519664291988
Rule of 40 score: -0.9158711020693232
Financial ratios for RBBN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.25
Shares outstanding: 176139067
Market cap (USD): 572451967.75
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RBBN — annual report dated 2024-12-31
Total revenue: 833881000
Gross profit: 439512000
Operating income: 27032000
Net income: -54235000
Capital expenditures: 22406000
Operating cash flow: 50240000
Depreciation & amortization: 64401000
Net tangible assets: -83808000
Owner earnings: -12240000
Capex to operating income (%): 82.88694880142053
Buffett classification: The Gruesome
Stock price: 4.16
Shares outstanding: 176139067
Book value: 404621000
P/B ratio: 1.8109255790480474
Market cap (USD): 732738518.72
Debt to equity: 0.9482206805875127
Current ratio: 1.4098512191636285
Quick ratio: 1.1690926284614425
Interest coverage ratio: 0.7915897976514685
COGS to revenue (%): 47.29319890967656
R&D to revenue (%): 21.57873845308863
SG&A to revenue (%): 24.77211976289183
Free cash flow (dilution-adjusted): 11286000
Buyback yield (%): 7.758565784054813
Retained earnings: -1574185000
Inventory turnover: 4.9807272130236555
Receivables turnover: 3.2737419420692686
Capitalized R&D asset: 374896280
ROCI (R&D-adjusted, %): 1.2864161515044652
Rosenberg metric: 0.1648431763348369
FCF margin (%): 1.3534305254586685
Revenue growth (%): 0.9127004776490036
Rule of 40 score: 2.266131003107672
Financial ratios for RBBN — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.16
Shares outstanding: 176139067
Market cap (USD): 732738518.72
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RBBN — quarterly report dated 2025-03-31
Total revenue: 181279000
Gross profit: 82370000
Operating income: -14269000
Net income: -26227000
Capital expenditures: 12149000
Operating cash flow: -3535000
Depreciation & amortization: 15012000
Net tangible assets: -95071000
Owner earnings: -23364000
Buffett classification: The Gruesome
Stock price: 3.92
Shares outstanding: 176139067
Book value: 381815000
P/B ratio: 1.8083761576679804
Market cap (USD): 690465142.64
Debt to equity: 1.0688396212825584
Current ratio: 1.392827183957009
Quick ratio: 1.13189593027066
Interest coverage ratio: -1.3263617772820226
COGS to revenue (%): 54.561752878160185
R&D to revenue (%): 24.03367185388269
SG&A to revenue (%): 25.880548767369632
Free cash flow (dilution-adjusted): -19982000
Buyback yield (%): 0
Retained earnings: -1600412000
Inventory turnover: 1.2420916477251323
Receivables turnover: 0.8039514823602457
Capitalized R&D asset: 43568000
ROCI (R&D-adjusted, %): 1.6870560341300695
FCF margin (%): -11.022788078045444
Rule of 40 score: -11.022788078045444
Financial ratios for RBBN — quarterly report dated 2025-06-30
Total revenue: 220583000
Gross profit: 109307000
Operating income: 9470000
Net income: -11093000
Capital expenditures: 5682000
Operating cash flow: -795000
Depreciation & amortization: 15540000
Net tangible assets: -95199000
Owner earnings: -1235000
Capex to operating income (%): 60
Buffett classification: The Good
Stock price: 4.01
Shares outstanding: 176139067
Book value: 370435000
P/B ratio: 1.9067249549043692
Market cap (USD): 706317658.67
Debt to equity: 1.1047930136191235
Current ratio: 1.3836534138556655
Quick ratio: 1.1276134417876469
Interest coverage ratio: 0.8381272678998142
COGS to revenue (%): 50.446317259262955
R&D to revenue (%): 20.262667567310263
SG&A to revenue (%): 22.289115661678373
Free cash flow (dilution-adjusted): -10954000
Buyback yield (%): 0.318978291473331
Retained earnings: -1611505000
Inventory turnover: 1.3857706820757418
Receivables turnover: 0.8845965672120629
Capitalized R&D asset: 73886560
ROCI (R&D-adjusted, %): 2.741974949177391
Rosenberg metric: 0.618274880646346
FCF margin (%): -4.96593119143361
Revenue growth (%): 21.68149647780493
Rule of 40 score: 16.715565286371323
Financial ratios for RBBN — quarterly report dated 2025-09-30
Total revenue: 215371000
Gross profit: 107966000
Operating income: 6708000
Net income: -12109000
Capital expenditures: 5537000
Operating cash flow: 26489000
Depreciation & amortization: 15415000
Net tangible assets: -94592000
Owner earnings: -2231000
Capex to operating income (%): 82.54323196183661
Buffett classification: The Gruesome
Stock price: 3.8
Shares outstanding: 176139067
Book value: 360052000
P/B ratio: 1.858977188295024
Market cap (USD): 669328454.6
Debt to equity: 1.13385288791619
Current ratio: 1.4335877810288
Quick ratio: 1.1594729232477028
Interest coverage ratio: 0.5686673448626653
COGS to revenue (%): 49.86975962409052
R&D to revenue (%): 21.30927562206611
SG&A to revenue (%): 22.951558009202724
Free cash flow (dilution-adjusted): 15108000
Buyback yield (%): 0.5196253014640624
Retained earnings: -1623614000
Inventory turnover: 1.3424450360593447
Receivables turnover: 0.9865284546887024
Capitalized R&D asset: 90217760
ROCI (R&D-adjusted, %): 0.8723838739309678
Rosenberg metric: -0.03000268480400931
FCF margin (%): 7.014872011552159
Revenue growth (%): -2.362829411151358
Rule of 40 score: 4.652042600400801
Financial ratios for RBBN — quarterly report dated 2025-12-31
Total revenue: 227323000
Gross profit: 121063000
Operating income: 18762000
Net income: 89065000
Capital expenditures: 1974000
Operating cash flow: 29239000
Depreciation & amortization: 14954000
Net tangible assets: 4758000
Owner earnings: 102045000
Return on net tangible assets (%): 2144.703656998739
Capex to operating income (%): 10.521266389510712
Buffett classification: The Great
Stock price: 2.88
P/E ratio: 12.79847898274296
Shares outstanding: 176139067
Book value: 448994000
P/B ratio: 1.1298157947767675
Market cap (USD): 507280512.96
Debt to equity: 0.9023127257825272
Current ratio: 1.4406462676679146
Quick ratio: 1.1908435904181975
Interest coverage ratio: 1.694697859271972
COGS to revenue (%): 46.74406021388069
R&D to revenue (%): 19.66980903824074
SG&A to revenue (%): 22.787399427246694
Free cash flow (dilution-adjusted): 22478000
Buyback yield (%): 0.6355458011165941
Retained earnings: -1534549000
Inventory turnover: 1.3483744892520875
Receivables turnover: 0.9803264549237769
Capitalized R&D asset: 90212660
ROCI (R&D-adjusted, %): 1.8616784275881153
Rosenberg metric: 0.28537499455266485
FCF margin (%): 9.888132745036799
Revenue growth (%): 5.549493664420929
Rule of 40 score: 15.437626409457728
Financial ratios for RBBN — annual report dated 2025-12-31
Total revenue: 844556000
Gross profit: 420706000
Operating income: 20671000
Net income: 39636000
Capital expenditures: 25342000
Operating cash flow: 51398000
Depreciation & amortization: 60921000
Net tangible assets: 4758000
Owner earnings: 75215000
Return on net tangible assets (%): 1580.8112652374948
Capex to operating income (%): 122.59687484882203
Buffett classification: The Gruesome
Stock price: 2.88
P/E ratio: 12.79847898274296
Shares outstanding: 176139067
Book value: 448994000
P/B ratio: 1.1298157947767675
Market cap (USD): 507280512.96
Debt to equity: 0.9023127257825272
Current ratio: 1.4406462676679146
Quick ratio: 1.1908435904181975
Interest coverage ratio: 0.4601326685068115
COGS to revenue (%): 50.18613330554753
R&D to revenue (%): 21.17941261443883
SG&A to revenue (%): 23.363045197713355
Free cash flow (dilution-adjusted): 6650000
Buyback yield (%): 1.765295486662252
Retained earnings: -1534549000
Inventory turnover: 5.378397583940309
Receivables turnover: 3.6421329538348752
Capitalized R&D asset: 362350270
ROCI (R&D-adjusted, %): 1.3013194660901943
Rosenberg metric: -0.10451203450019729
FCF margin (%): 0.7873959808467408
Revenue growth (%): 1.2801586797156908
Rule of 40 score: 2.0675546605624318
Financial ratios for REFEX.NS — annual report dated 2022-03-31
Capital expenditures: 0
Depreciation & amortization: 744758.0113411578
Buffett classification: The Gruesome
Stock price: 0.31306870631676115
Shares outstanding: 137219448
Market cap (USD): 42959115.06686008
Buyback yield (%): 0
Retained earnings: 15317605.169457998
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for REFEX.NS — annual report dated 2023-03-31
Total revenue: 197065152.2533496
Gross profit: 23804116.930572473
Operating income: 20540060.901339833
Net income: 14136516.443361755
Capital expenditures: 8695481.120584654
Operating cash flow: 3363617.539585871
Depreciation & amortization: 839269.1839220463
Net tangible assets: 38288319.12302071
Owner earnings: 6280304.506699149
Return on net tangible assets (%): 16.402664443222157
Capex to operating income (%): 42.33425189122709
Buffett classification: The Good
Stock price: 0.5760048721071864
P/E ratio: 5.591127836375417
Shares outstanding: 137219448
Book value: 38293995.12789282
P/B ratio: 2.064006911054515
Market cap (USD): 79039070.59585872
Debt to equity: 0.4752716100863344
Current ratio: 1.5851146564883656
Quick ratio: 1.5525424065754136
Effective tax rate (%): 25.78577905211585
Interest coverage ratio: 18.24213020055819
COGS to revenue (%): 87.92068680921852
SG&A to revenue (%): 0.34024867592650215
Free cash flow (dilution-adjusted): -5435261.875761267
Buyback yield (%): 0
Retained earnings: 28284311.81485993
Inventory turnover: 131.53995746254856
Receivables turnover: 6.599246385394985
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 40.12221253074585
FCF margin (%): -2.7581040146426403
Rule of 40 score: -2.7581040146426403
Financial ratios for REFEX.NS — annual report dated 2024-03-31
Total revenue: 165140256.62549466
Gross profit: 22455798.057321023
Operating income: 16620482.07219091
Net income: 11256685.453891354
Capital expenditures: 6082120.158292362
Operating cash flow: 341587.7203501619
Depreciation & amortization: 1624319.4627653195
Net tangible assets: 55610804.65283607
Owner earnings: 6798884.758364311
Return on net tangible assets (%): 12.225834171629053
Capex to operating income (%): 36.594126042040955
Buffett classification: The Good
Stock price: 1.6077255278310942
P/E ratio: 19.598238786020953
Shares outstanding: 137219448
Book value: 55724799.13658713
P/B ratio: 3.9589413130723177
Market cap (USD): 220611209.4644914
Debt to equity: 0.4617325863679608
Current ratio: 2.5894738253635143
Quick ratio: 2.5521777856630425
Effective tax rate (%): 23.368298032092138
Interest coverage ratio: 8.058784538096567
COGS to revenue (%): 86.40198427918983
SG&A to revenue (%): 0.6199165989279246
Free cash flow (dilution-adjusted): -5767214.29427989
Buyback yield (%): 0
Retained earnings: 38440520.44609665
Inventory turnover: 164.53877534087454
Receivables turnover: 4.501205296571597
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.94341329255334
FCF margin (%): -3.4923127843738238
Revenue growth (%): -16.200173020348046
Rule of 40 score: -19.69248580472187
Financial ratios for REFEX.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 280327.2814142379
Net tangible assets: 72826433.34925944
Buffett classification: The Gruesome
Stock price: 6.712255136168181
Shares outstanding: 137219448
Book value: 73038377.9264214
P/B ratio: 12.61052026029421
Market cap (USD): 921051944.6201626
Debt to equity: 0.38545110341790284
Current ratio: 2.5719816282656347
Quick ratio: 2.5304968399407297
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for REFEX.NS — quarterly report dated 2024-12-31
Total revenue: 79967560.32171582
Gross profit: 8326588.18044061
Operating income: 5889707.425107821
Net income: 5834432.917589462
Capital expenditures: 0
Depreciation & amortization: 306585.84916656953
Owner earnings: 6141018.766756032
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.596922718265532
P/E ratio: 32.90836730608787
Shares outstanding: 137219448
Market cap (USD): 768006645.8990557
Effective tax rate (%): 17.017143750310833
Interest coverage ratio: 10.749452185937665
COGS to revenue (%): 89.58754256483242
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for REFEX.NS — quarterly report dated 2025-03-31
Total revenue: 69496679.91582885
Gross profit: 9113198.503624035
Operating income: 6677414.075286415
Net income: 5648433.481412204
Capital expenditures: 0
Depreciation & amortization: 1358802.899228431
Net tangible assets: 139303518.82160392
Owner earnings: 7007236.380640635
Return on net tangible assets (%): 5.030193379116505
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.413583848757148
P/E ratio: 26.805199238920387
Shares outstanding: 137219448
Book value: 141708428.8052373
P/B ratio: 4.273772171029734
Market cap (USD): 605629539.4281714
Debt to equity: 0.2359899021089301
Current ratio: 3.4871350900091964
Quick ratio: 3.4684223330617865
Effective tax rate (%): 10.680181625032
Interest coverage ratio: 11.08517864420595
COGS to revenue (%): 86.88685773959054
Buyback yield (%): 0
Retained earnings: 55963455.69324292
Inventory turnover: 69.65977963290132
Receivables turnover: 0.847527011533418
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.071346392040779
Revenue growth (%): -13.093910035221512
Rule of 40 score: -13.093910035221512
Financial ratios for REFEX.NS — annual report dated 2025-03-31
Total revenue: 263250374.0939911
Gross profit: 29839244.797755435
Operating income: 23099567.453822773
Net income: 18561865.793780684
Capital expenditures: 25788578.44283376
Operating cash flow: -29051110.59153612
Depreciation & amortization: 3806862.2866495205
Net tangible assets: 139303518.82160392
Owner earnings: -3419850.362403553
Return on net tangible assets (%): -2.4549633715879864
Capex to operating income (%): 111.64095818844426
Buffett classification: The Gruesome
Stock price: 4.413583848757148
P/E ratio: 32.62762192963882
Shares outstanding: 137219448
Book value: 141708428.8052373
P/B ratio: 4.273772171029734
Market cap (USD): 605629539.4281714
Debt to equity: 0.2359899021089301
Current ratio: 3.4871350900091964
Quick ratio: 3.4684223330617865
Effective tax rate (%): 21.335114747094114
Interest coverage ratio: 15.624131196280453
COGS to revenue (%): 88.66507031549304
SG&A to revenue (%): 0.5573299780975028
Free cash flow (dilution-adjusted): -54936520.92588262
Buyback yield (%): 0
Retained earnings: 55963455.69324292
Inventory turnover: 269.2684729396215
Receivables turnover: 3.210395131266087
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.084245720045448
FCF margin (%): -20.86854429550328
Revenue growth (%): 59.41017621826199
Rule of 40 score: 38.54163192275871
Financial ratios for REFEX.NS — quarterly report dated 2025-06-30
Total revenue: 44845471.56564475
Gross profit: 7072337.935876434
Operating income: 2773671.8932834077
Net income: 2477428.0365083083
Capital expenditures: 0
Depreciation & amortization: 1654446.5246899135
Owner earnings: 4131874.5611982215
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.353264685232858
P/E ratio: 52.61866277240251
Shares outstanding: 137219448
Market cap (USD): 734572025.1055466
Effective tax rate (%): 15.886786736377523
Interest coverage ratio: 2.3873059995367156
COGS to revenue (%): 84.22953825889877
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -35.471059020431625
Rule of 40 score: -35.471059020431625
Financial ratios for REFEX.NS — quarterly report dated 2025-12-31
Total revenue: 64165333.630388774
Gross profit: 12244836.805168765
Operating income: 9437718.614236383
Net income: 6006449.816196948
Capital expenditures: 0
Depreciation & amortization: 561401.3590286288
Owner earnings: 6567851.175225577
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.895176562325944
P/E ratio: 19.89681065359173
Shares outstanding: 137219448
Market cap (USD): 397274529.7449036
Effective tax rate (%): 24.626992221580508
Interest coverage ratio: 9.267077212517638
COGS to revenue (%): 80.916740999583
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 43.08096534666524
Rule of 40 score: 43.08096534666524
Financial ratios for ROP — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 477.07
Shares outstanding: 98900000
Market cap (USD): 47182223000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ROP — annual report dated 2022-12-31
Total revenue: 5371800000
Gross profit: 3752800000
Operating income: 1524500000
Net income: 4544700000
Capital expenditures: 70300000
Operating cash flow: 734600000
Depreciation & amortization: 650100000
Net tangible assets: -7939000000
Owner earnings: 5124500000
Return on net tangible assets (%): -64.54843179241718
Capex to operating income (%): 4.611347982945228
Buffett classification: The Great
Stock price: 421.53
P/E ratio: 9.173172486632781
Shares outstanding: 98900000
Book value: 16037800000
P/B ratio: 2.5994411328237037
Market cap (USD): 41689317000
Debt to equity: 0.4182680916335158
Current ratio: 0.6680726015557477
Quick ratio: 0.6295937770095074
Effective tax rate (%): 23.1201248049922
Interest coverage ratio: 7.923596673596673
COGS to revenue (%): 30.13887337577721
SG&A to revenue (%): 41.481440113183666
Free cash flow (dilution-adjusted): 545800000
Buyback yield (%): 0
Retained earnings: 13730700000
Inventory turnover: 14.54627133872417
Receivables turnover: 6.125199543899658
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.3287986283797535
FCF margin (%): 10.160467627238543
Rule of 40 score: 10.160467627238543
Financial ratios for ROP — annual report dated 2023-12-31
Total revenue: 6177800000
Gross profit: 4307200000
Operating income: 1745200000
Net income: 1384200000
Capital expenditures: 108000000
Operating cash flow: 2035100000
Depreciation & amortization: 755200000
Net tangible assets: -7886100000
Owner earnings: 2031400000
Return on net tangible assets (%): -25.75924728319448
Capex to operating income (%): 6.18840247536099
Buffett classification: The Great
Stock price: 535.02
P/E ratio: 38.22675769397486
Shares outstanding: 98900000
Book value: 17444800000
P/B ratio: 3.0331948775566357
Market cap (USD): 52913478000
Debt to equity: 0.3653466935705769
Current ratio: 0.499932505399568
Quick ratio: 0.45990820734341253
Effective tax rate (%): 21.496184957833744
Interest coverage ratio: 10.596235579842137
COGS to revenue (%): 30.279387484217686
SG&A to revenue (%): 41.47107384505811
Free cash flow (dilution-adjusted): 1803600000
Buyback yield (%): 0
Retained earnings: 14816300000
Inventory turnover: 15.772344013490725
Receivables turnover: 6.278252032520325
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.924215312466524
FCF margin (%): 29.19485901129852
Revenue growth (%): 15.00428161882423
Rule of 40 score: 44.19914063012275
Financial ratios for ROP — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 548.35
Shares outstanding: 98900000
Market cap (USD): 54231815000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ROP — annual report dated 2024-12-31
Total revenue: 7039200000
Gross profit: 4878300000
Operating income: 1996800000
Net income: 1549300000
Capital expenditures: 111000000
Operating cash flow: 2393200000
Depreciation & amortization: 812800000
Net tangible assets: -9504900000
Owner earnings: 2251100000
Return on net tangible assets (%): -23.68357373565214
Capex to operating income (%): 5.558894230769231
Buffett classification: The Great
Stock price: 513.01
P/E ratio: 32.74813722326212
Shares outstanding: 98900000
Book value: 18867600000
P/B ratio: 2.6890907693612327
Market cap (USD): 50736689000
Debt to equity: 0.4064745913629714
Current ratio: 0.4025624967381661
Quick ratio: 0.37104013360471794
Effective tax rate (%): 21.243391622610815
Interest coverage ratio: 7.703703703703703
COGS to revenue (%): 30.698090692124104
SG&A to revenue (%): 40.93504943743607
Free cash flow (dilution-adjusted): 2136300000
Buyback yield (%): 0
Retained earnings: 16034900000
Inventory turnover: 17.888245033112582
Receivables turnover: 6.78150289017341
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.260430869920917
FCF margin (%): 30.348619161268324
Revenue growth (%): 13.943475023471139
Rule of 40 score: 44.29209418473946
Financial ratios for ROP — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 513.01
Shares outstanding: 98900000
Market cap (USD): 50736689000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ROP — quarterly report dated 2025-03-31
Total revenue: 1882800000
Gross profit: 1293700000
Operating income: 525800000
Net income: 331100000
Capital expenditures: 21900000
Operating cash flow: 528700000
Depreciation & amortization: 213100000
Net tangible assets: -9101500000
Owner earnings: 522300000
Return on net tangible assets (%): -5.738614514091084
Capex to operating income (%): 4.165081780144542
Buffett classification: The Great
Stock price: 582.76
P/E ratio: 43.517792207792205
Shares outstanding: 98900000
Book value: 19223600000
P/B ratio: 2.998135833038557
Market cap (USD): 57634964000
Debt to equity: 0.3878774006949791
Current ratio: 0.4622017353579176
Quick ratio: 0.4281724511930586
Effective tax rate (%): 20.789473684210527
Interest coverage ratio: 8.359300476947535
COGS to revenue (%): 31.28850647971107
SG&A to revenue (%): 40.785001062247716
Free cash flow (dilution-adjusted): 468000000
Buyback yield (%): 0
Retained earnings: 16276900000
Inventory turnover: 4.69402390438247
Receivables turnover: 1.9424326833797585
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8960866617623726
FCF margin (%): 24.8565965583174
Rule of 40 score: 24.8565965583174
Financial ratios for ROP — quarterly report dated 2025-06-30
Total revenue: 1943600000
Gross profit: 1345400000
Operating income: 548300000
Net income: 378300000
Capital expenditures: 30900000
Operating cash flow: 404100000
Depreciation & amortization: 223700000
Net tangible assets: -10501100000
Owner earnings: 571100000
Return on net tangible assets (%): -5.438477873746559
Capex to operating income (%): 5.63560094838592
Buffett classification: The Great
Stock price: 561.08
P/E ratio: 78.22217648717226
Shares outstanding: 98900000
Book value: 19633900000
P/B ratio: 2.8262755743891943
Market cap (USD): 55490812000.00001
Debt to equity: 0.45120938784449344
Current ratio: 0.46410436246317854
Quick ratio: 0.4270164118389676
Effective tax rate (%): 22.048217597362456
Interest coverage ratio: 6.93173198482933
COGS to revenue (%): 30.77793784729368
SG&A to revenue (%): 41.011525005145096
Free cash flow (dilution-adjusted): 329300000
Buyback yield (%): 0
Retained earnings: 16565900000
Inventory turnover: 4.524962178517398
Receivables turnover: 1.8356630147336608
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8488732427611372
FCF margin (%): 16.94278658160115
Revenue growth (%): 3.229233057148927
Rule of 40 score: 20.17201963875008
Financial ratios for ROP — quarterly report dated 2025-09-30
Total revenue: 2017500000
Gross profit: 1403000000
Operating income: 573000000
Net income: 398500000
Capital expenditures: 27600000
Operating cash flow: 869500000
Depreciation & amortization: 231100000
Net tangible assets: -11310400000
Owner earnings: 602000000
Return on net tangible assets (%): -5.322535012024331
Capex to operating income (%): 4.81675392670157
Buffett classification: The Great
Stock price: 494.34
P/E ratio: 44.128735445437314
Shares outstanding: 98900000
Book value: 19992800000
P/B ratio: 2.445391640990757
Market cap (USD): 48890226000
Debt to equity: 0.4728752350846305
Current ratio: 0.5769870728273391
Quick ratio: 0.5319339562268015
Effective tax rate (%): 20.012043356081897
Interest coverage ratio: 6.3879598662207355
COGS to revenue (%): 30.458488228004953
SG&A to revenue (%): 41.14002478314746
Free cash flow (dilution-adjusted): 795900000
Buyback yield (%): 0
Retained earnings: 16875000000
Inventory turnover: 4.364346590909091
Receivables turnover: 1.810066391530594
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8214067744888616
FCF margin (%): 39.44981412639405
Revenue growth (%): 3.8022226795636964
Rule of 40 score: 43.25203680595775
Financial ratios for ROP — annual report dated 2025-12-31
Total revenue: 7902500000
Gross profit: 5472000000
Operating income: 2235400000
Net income: 1536300000
Capital expenditures: 104700000
Operating cash flow: 2540300000
Depreciation & amortization: 898200000
Net tangible assets: -11223900000
Owner earnings: 2329800000
Return on net tangible assets (%): -20.757490711784673
Capex to operating income (%): 4.683725507739108
Buffett classification: The Great
Stock price: 441.98
P/E ratio: 28.452660287704227
Shares outstanding: 98900000
Book value: 19881500000
P/B ratio: 2.1986179111234065
Market cap (USD): 43711822000
Debt to equity: 0.47025123858863765
Current ratio: 0.5175273781404337
Quick ratio: 0.47949323598883403
Effective tax rate (%): 20.649759826455245
Interest coverage ratio: 6.878153846153846
COGS to revenue (%): 30.756089844985762
SG&A to revenue (%): 40.95665928503638
Free cash flow (dilution-adjusted): 2269300000
Buyback yield (%): 1.1438553167607608
Retained earnings: 17205700000
Inventory turnover: 17.15243472124206
Receivables turnover: 6.305857006064475
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.2457003571961085
FCF margin (%): 28.71622904144258
Revenue growth (%): 12.264177747471305
Rule of 40 score: 40.98040678891388
Financial ratios for ROP — quarterly report dated 2025-12-31
Total revenue: 2058600000
Gross profit: 1429900000
Operating income: 588300000
Net income: 428400000
Capital expenditures: 24300000
Operating cash flow: 738000000
Depreciation & amortization: 230300000
Net tangible assets: -11223900000
Owner earnings: 634400000
Return on net tangible assets (%): -5.652224271420807
Capex to operating income (%): 4.130545639979602
Buffett classification: The Great
Stock price: 441.98
P/E ratio: 28.452660287704227
Shares outstanding: 98900000
Book value: 19881500000
P/B ratio: 2.1986179111234065
Market cap (USD): 43711822000
Debt to equity: 0.47025123858863765
Current ratio: 0.5175273781404337
Quick ratio: 0.47949323598883403
Effective tax rate (%): 19.865319865319865
Interest coverage ratio: 6.305466237942122
COGS to revenue (%): 30.540172933061307
SG&A to revenue (%): 40.88215291945983
Free cash flow (dilution-adjusted): 676100000
Buyback yield (%): 0
Retained earnings: 17205700000
Inventory turnover: 4.436838390966831
Receivables turnover: 1.6426747526332588
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9068826698302184
FCF margin (%): 32.84270863693772
Revenue growth (%): 2.037174721189591
Rule of 40 score: 34.879883358127316
Financial ratios for SDGR — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 2847000
Buffett classification: The Gruesome
Stock price: 34.83
Shares outstanding: 65556531
Market cap (USD): 2283333974.73
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SDGR — annual report dated 2022-12-31
Total revenue: 180955000
Gross profit: 101022000
Operating income: -146817000
Net income: -149186000
Capital expenditures: 8014000
Operating cash flow: -119683000
Depreciation & amortization: 4344000
Net tangible assets: 442516000
Owner earnings: -152856000
Return on net tangible assets (%): -34.54247981993871
Buffett classification: The Gruesome
Stock price: 18.69
Shares outstanding: 65556531
Book value: 447905000
P/B ratio: 2.7355166037217717
Market cap (USD): 1225251564.39
Debt to equity: 0.260079704401603
Current ratio: 4.90803224294341
Quick ratio: 4.90803224294341
COGS to revenue (%): 44.17286065596419
R&D to revenue (%): 69.83614710839711
SG&A to revenue (%): 67.1255284462988
Free cash flow (dilution-adjusted): -167327000
Buyback yield (%): 0
Retained earnings: -379138000
Receivables turnover: 2.6191199884209
Capitalized R&D asset: 126372000
ROCI (R&D-adjusted, %): -8.860456553755522
FCF margin (%): -92.46884584565224
Rule of 40 score: -92.46884584565224
Financial ratios for SDGR — annual report dated 2023-12-31
Total revenue: 216666000
Gross profit: 140692000
Operating income: -177448000
Net income: 40720000
Capital expenditures: 13403000
Operating cash flow: -136733000
Depreciation & amortization: 5552000
Net tangible assets: 543767000
Owner earnings: 32869000
Return on net tangible assets (%): 6.044684579976351
Buffett classification: The Gruesome
Stock price: 35.8
P/E ratio: 57.63565348231827
Shares outstanding: 65556531
Book value: 548558000
P/B ratio: 4.278351258754771
Market cap (USD): 2346923809.7999997
Debt to equity: 0.23312393584634625
Current ratio: 4.247649113882384
Quick ratio: 4.247649113882384
Effective tax rate (%): 5.123604930217386
COGS to revenue (%): 35.06503096932606
R&D to revenue (%): 83.89225813002501
SG&A to revenue (%): 62.94203982166099
Free cash flow (dilution-adjusted): -197977000
Buyback yield (%): 0
Retained earnings: -338418000
Receivables turnover: 2.431280578122896
Capitalized R&D asset: 266435240
ROCI (R&D-adjusted, %): -10.515427359943338
Rosenberg metric: 0.31391447472541384
FCF margin (%): -91.37428115163432
Revenue growth (%): 19.734740681384874
Rule of 40 score: -71.63954047024944
Financial ratios for SDGR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.55
Shares outstanding: 65556531
Market cap (USD): 1216073650.05
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SDGR — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 19.29
Shares outstanding: 65556531
Market cap (USD): 1264585482.99
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SDGR — annual report dated 2024-12-31
Total revenue: 207539000
Gross profit: 132083000
Operating income: -209296000
Net income: -187123000
Capital expenditures: 7311000
Operating cash flow: -157368000
Depreciation & amortization: 6159000
Net tangible assets: 416654000
Owner earnings: -188275000
Return on net tangible assets (%): -45.187373696160364
Buffett classification: The Gruesome
Stock price: 19.29
Shares outstanding: 65556531
Book value: 421445000
P/B ratio: 3.000594343247636
Market cap (USD): 1264585482.99
Debt to equity: 0.27958333827664344
Current ratio: 3.3116189562287808
Quick ratio: 3.3116189562287808
COGS to revenue (%): 36.35750389083498
R&D to revenue (%): 97.22750904649247
SG&A to revenue (%): 67.26157493290418
Free cash flow (dilution-adjusted): -214582000
Buyback yield (%): 0
Retained earnings: -525541000
Receivables turnover: 0.8128169880117337
Capitalized R&D asset: 365270980
ROCI (R&D-adjusted, %): -17.80640450409975
Rosenberg metric: -0.047363093207750624
FCF margin (%): -103.39357903815669
Revenue growth (%): -4.212474499921538
Rule of 40 score: -107.60605353807823
Financial ratios for SDGR — quarterly report dated 2025-03-31
Total revenue: 59551000
Gross profit: 31124000
Operating income: -50889000
Net income: -59808000
Capital expenditures: 596000
Operating cash flow: 144063000
Depreciation & amortization: 1589000
Net tangible assets: 368713000
Owner earnings: -58815000
Return on net tangible assets (%): -15.951431058845225
Buffett classification: The Gruesome
Stock price: 19.74
Shares outstanding: 65556531
Book value: 373504000
P/B ratio: 3.4647177056738343
Market cap (USD): 1294085921.9399998
Debt to equity: 0.31100068540095954
Current ratio: 3.450396441694063
Quick ratio: 3.450396441694063
COGS to revenue (%): 47.73555439875065
R&D to revenue (%): 76.98275427784587
SG&A to revenue (%): 60.73617571493342
Free cash flow (dilution-adjusted): 131893000
Buyback yield (%): 0
Retained earnings: -585349000
Receivables turnover: 1.2856433506044904
Capitalized R&D asset: 45844000
ROCI (R&D-adjusted, %): -3.260539446864848
FCF margin (%): 221.47906836157242
Rule of 40 score: 221.47906836157242
Financial ratios for SDGR — quarterly report dated 2025-06-30
Total revenue: 54759000
Gross profit: 26158000
Operating income: -52903000
Net income: -43173000
Capital expenditures: 314000
Operating cash flow: -52198000
Depreciation & amortization: 1531000
Net tangible assets: 338081000
Owner earnings: -41956000
Return on net tangible assets (%): -12.410043746912722
Buffett classification: The Gruesome
Stock price: 20.12
Shares outstanding: 65556531
Book value: 342872000
P/B ratio: 3.846909061457337
Market cap (USD): 1318997403.72
Debt to equity: 0.33339846939965934
Current ratio: 3.2997258761371007
Quick ratio: 3.2997258761371007
COGS to revenue (%): 52.23068354060519
R&D to revenue (%): 78.77791778520425
SG&A to revenue (%): 65.60200149747072
Free cash flow (dilution-adjusted): -63139000
Buyback yield (%): 0
Retained earnings: -628522000
Receivables turnover: 1.488663549369291
Capitalized R&D asset: 73853480
ROCI (R&D-adjusted, %): -6.502361008453153
Rosenberg metric: -0.10832388098769741
FCF margin (%): -115.30342044230173
Revenue growth (%): -8.046884183305066
Rule of 40 score: -123.3503046256068
Financial ratios for SDGR — quarterly report dated 2025-09-30
Total revenue: 54324000
Gross profit: 28039000
Operating income: -45947000
Net income: -32795000
Capital expenditures: 491000
Operating cash flow: -61873000
Depreciation & amortization: 1465000
Net tangible assets: 316561000
Owner earnings: -31821000
Return on net tangible assets (%): -10.05209106617682
Buffett classification: The Gruesome
Stock price: 20.06
Shares outstanding: 65556531
Book value: 321352000
P/B ratio: 4.092285132378202
Market cap (USD): 1315064011.86
Debt to equity: 0.3467661629614877
Current ratio: 3.250721851246959
Quick ratio: 3.250721851246959
COGS to revenue (%): 48.385612252411455
R&D to revenue (%): 78.7073853177233
SG&A to revenue (%): 57.48656210882851
Free cash flow (dilution-adjusted): -73210000
Buyback yield (%): 0
Retained earnings: -661317000
Receivables turnover: 0.946411149825784
Capitalized R&D asset: 86787980
ROCI (R&D-adjusted, %): -7.912016189608076
Rosenberg metric: 0.04360424683573647
FCF margin (%): -134.76548118695234
Revenue growth (%): -0.794389963293705
Rule of 40 score: -135.55987115024604
Financial ratios for SDGR — annual report dated 2025-12-31
Total revenue: 255869000
Gross profit: 142614000
Operating income: -166896000
Net income: -103265000
Capital expenditures: 1442000
Operating cash flow: 13899000
Depreciation & amortization: 6022000
Net tangible assets: 359262000
Owner earnings: -98685000
Return on net tangible assets (%): -27.46881106267849
Buffett classification: The Gruesome
Stock price: 17.88
Shares outstanding: 65556531
Book value: 364053000
P/B ratio: 3.219725628630996
Market cap (USD): 1172150774.28
Debt to equity: 0.3000332369188003
Current ratio: 2.7454582945605277
Quick ratio: 2.7454582945605277
COGS to revenue (%): 44.26288452293947
R&D to revenue (%): 67.66665754741685
SG&A to revenue (%): 53.29758587402147
Free cash flow (dilution-adjusted): -30540000
Buyback yield (%): 0
Retained earnings: -628806000
Receivables turnover: 2.4510168306304063
Capitalized R&D asset: 368316730
ROCI (R&D-adjusted, %): -19.807017850616308
Rosenberg metric: 0.0521892112892435
FCF margin (%): -11.935795270235941
Revenue growth (%): 23.28718939572803
Rule of 40 score: 11.35139412549209
Financial ratios for SDGR — quarterly report dated 2025-12-31
Total revenue: 87235000
Gross profit: 57293000
Operating income: -17157000
Net income: 32511000
Capital expenditures: 41000
Operating cash flow: -16093000
Depreciation & amortization: 1437000
Net tangible assets: 359262000
Owner earnings: 33907000
Return on net tangible assets (%): 9.437958926911278
Buffett classification: The Gruesome
Stock price: 17.88
P/E ratio: 9.013493696594999
Shares outstanding: 65556531
Book value: 364053000
P/B ratio: 3.219725628630996
Market cap (USD): 1172150774.28
Debt to equity: 0.3000332369188003
Current ratio: 2.7454582945605277
Quick ratio: 2.7454582945605277
Effective tax rate (%): 1.401146392502957
COGS to revenue (%): 34.32337937754342
R&D to revenue (%): 47.45686937582392
SG&A to revenue (%): 37.887315870923366
Free cash flow (dilution-adjusted): -26084000
Buyback yield (%): 0
Retained earnings: -628806000
Receivables turnover: 0.8356403207111588
Capitalized R&D asset: 84281730
ROCI (R&D-adjusted, %): -2.927597872521365
Rosenberg metric: 0.6841920621184835
FCF margin (%): -29.90084255172809
Revenue growth (%): 60.582799499300485
Rule of 40 score: 30.681956947572395
Financial ratios for SGML — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 35818.48818897638
Buffett classification: The Gruesome
Stock price: 10.41
Shares outstanding: 112064646
Market cap (USD): 1166592964.8600001
Buyback yield (%): 0
Capitalized R&D asset: 768244.8582677165
Rule of 40 score: 0
Financial ratios for SGML — annual report dated 2022-12-31
Total revenue: 0
Gross profit: 0
Operating income: -70059898.40441176
Net income: -68918924.77941176
Capital expenditures: 61521558.22794117
Operating cash flow: -2948869.6470588236
Depreciation & amortization: 55260.83088235294
Net tangible assets: 99201860.22794117
Owner earnings: -130385222.17647058
Return on net tangible assets (%): -131.43425120948115
Buffett classification: The Gruesome
Stock price: 28.22
Shares outstanding: 112064646
Book value: 99201860.23529412
P/B ratio: 31.87908273714867
Market cap (USD): 3162464310.12
Debt to equity: 0.4429510775113405
Current ratio: 3.057902889619225
Quick ratio: 3.057902889619225
Interest coverage ratio: -375.91860772899366
Free cash flow (dilution-adjusted): -124921442.93382353
Buyback yield (%): 0
Retained earnings: -105380779.63235295
Receivables turnover: 0
Capitalized R&D asset: 1287833.9153334876
ROCI (R&D-adjusted, %): -47.047872492853124
Rule of 40 score: 0
Financial ratios for SGML — annual report dated 2023-12-31
Total revenue: 103494807.87121211
Gross profit: 50765456.46212121
Operating income: -13766109.765151516
Net income: -21840978.757575758
Capital expenditures: 26144529.878787875
Operating cash flow: -17584255.03030303
Depreciation & amortization: 4309832.840909091
Net tangible assets: 122462121.2121212
Owner earnings: -43675675.79545455
Return on net tangible assets (%): -35.664640921744514
Buffett classification: The Gruesome
Stock price: 31.53
Shares outstanding: 112064646
Book value: 122462121.21212119
P/B ratio: 28.852989425682654
Market cap (USD): 3533398288.38
Debt to equity: 0.8243055985153109
Current ratio: 1.16589756921877
Quick ratio: 1.0070193682568567
Interest coverage ratio: -1.3117483809302513
COGS to revenue (%): 50.94878911675141
SG&A to revenue (%): 57.42781312278068
Free cash flow (dilution-adjusted): -70563162.15151516
Buyback yield (%): 0
Retained earnings: -133019696.96969697
Inventory turnover: 4.7455337737778684
Receivables turnover: 3.821453645976111
Capitalized R&D asset: 771504.4096254052
ROCI (R&D-adjusted, %): -6.823028372165192
Rosenberg metric: 65.66396196629583
FCF margin (%): -68.18038856531165
Rule of 40 score: -68.18038856531165
Financial ratios for SGML — quarterly report dated 2024-09-30
Operating income: -11596296.296296295
Capital expenditures: 2907561.644444444
Depreciation & amortization: 1428888.8888888888
Buffett classification: The Gruesome
Stock price: 12.36
Shares outstanding: 112064646
Market cap (USD): 1385119024.56
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SGML — annual report dated 2024-12-31
Total revenue: 105840559.44055945
Gross profit: 22121678.32167832
Operating income: -6258041.9580419585
Net income: -35941258.74125874
Capital expenditures: 13911888.111888113
Operating cash flow: -12795804.195804195
Depreciation & amortization: 9623076.923076924
Net tangible assets: 64573426.573426574
Owner earnings: -40230069.93006993
Return on net tangible assets (%): -62.3012778860732
Buffett classification: The Gruesome
Stock price: 11.22
Shares outstanding: 112064646
Book value: 64573426.573426574
P/B ratio: 19.471869387173488
Market cap (USD): 1257365328.1200001
Debt to equity: 1.914522417153996
Current ratio: 0.852901968355536
Quick ratio: 0.7045168289341829
Interest coverage ratio: -0.3940901884798309
COGS to revenue (%): 79.09905386119773
SG&A to revenue (%): 19.316560071885405
Free cash flow (dilution-adjusted): -32373426.573426574
Buyback yield (%): 0
Retained earnings: -158728671.32867134
Inventory turnover: 7.4174721189591075
Receivables turnover: 8.402376061733193
Capitalized R&D asset: 255126.25389705878
ROCI (R&D-adjusted, %): -4.260179102766253
FCF margin (%): -30.5869760558169
Revenue growth (%): 2.266540339169832
Rule of 40 score: -28.32043571664707
Financial ratios for SGML — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 5979.881118881119
Buffett classification: The Gruesome
Stock price: 11.22
Shares outstanding: 112064646
Market cap (USD): 1257365328.1200001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SGML — quarterly report dated 2025-03-31
Total revenue: 33337762.23776224
Gross profit: 9409090.90909091
Operating income: 4656643.356643356
Net income: 3306293.7062937063
Capital expenditures: 2622377.6223776224
Operating cash flow: -1528671.3286713287
Depreciation & amortization: 2251048.951048951
Net tangible assets: 74190909.0909091
Owner earnings: 2934965.034965035
Return on net tangible assets (%): 3.9559631643935034
Capex to operating income (%): 56.31476197627272
Buffett classification: The Good
Stock price: 10.4
P/E ratio: 88.1252863426396
Shares outstanding: 112064646
Book value: 74190909.0909091
P/B ratio: 15.709098765347385
Market cap (USD): 1165472318.4
Debt to equity: 1.6192774264089056
Current ratio: 0.8539479769290506
Quick ratio: 0.6686823207071367
Effective tax rate (%): 51.398026315789465
Interest coverage ratio: 1.3149684044233807
COGS to revenue (%): 71.7764772512743
SG&A to revenue (%): 12.10118935246366
Free cash flow (dilution-adjusted): -5141258.741258741
Buyback yield (%): 0
Retained earnings: -155422377.62237763
Inventory turnover: 1.6116239638281837
Receivables turnover: 1.319704351677555
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.8492576269735994
FCF margin (%): -15.421727183101547
Rule of 40 score: -15.421727183101547
Financial ratios for SGML — quarterly report dated 2025-06-30
Total revenue: 12327007.299270073
Gross profit: -4872992.700729927
Operating income: -9020437.956204379
Net income: -13765693.430656934
Capital expenditures: 2389781.02189781
Operating cash flow: -4393430.656934306
Depreciation & amortization: 2394890.510948905
Net tangible assets: 67097080.2919708
Owner earnings: -13760583.941605838
Return on net tangible assets (%): -20.508469044743972
Buffett classification: The Gruesome
Stock price: 4.5
Shares outstanding: 112064646
Book value: 67097080.29197082
P/B ratio: 7.515839807121177
Market cap (USD): 504290907
Debt to equity: 1.8678350358452176
Current ratio: 0.6047390735137291
Quick ratio: 0.3917495383174815
Interest coverage ratio: -2.4198159389073823
COGS to revenue (%): 139.5310279488394
SG&A to revenue (%): 29.375888204642347
Free cash flow (dilution-adjusted): -6637226.277372262
Buyback yield (%): 0
Retained earnings: -175994890.5109489
Inventory turnover: 0.9592119189123178
Receivables turnover: 0.741352063213345
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.5953491320371995
FCF margin (%): -53.84296541923259
Revenue growth (%): -63.023891011775625
Rule of 40 score: -116.86685643100822
Financial ratios for SGML — quarterly report dated 2025-09-30
Total revenue: 20538848.92086331
Gross profit: -1102877.6978417267
Operating income: -6522302.158273382
Net income: -8327338.129496403
Capital expenditures: 6782014.388489209
Operating cash flow: -1145323.7410071944
Depreciation & amortization: 2032374.1007194247
Net tangible assets: 60266187.05035972
Owner earnings: -13076978.417266186
Return on net tangible assets (%): -21.698698818192668
Buffett classification: The Gruesome
Stock price: 6.41
Shares outstanding: 112064646
Book value: 60266187.050359726
P/B ratio: 11.919360026207471
Market cap (USD): 718334380.86
Debt to equity: 1.9865345589113046
Current ratio: 0.48938557935097726
Quick ratio: 0.31548676704386047
Interest coverage ratio: -1.4775097783572362
COGS to revenue (%): 105.36971522645275
SG&A to revenue (%): 18.091701986059057
Free cash flow (dilution-adjusted): -11064748.20143885
Buyback yield (%): 0
Retained earnings: -181789928.05755398
Inventory turnover: 1.3481222550864929
Receivables turnover: 1.0647447133852983
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.2265143144851125
FCF margin (%): -53.87228974745175
Revenue growth (%): 66.616668768254
Rule of 40 score: 12.74437902080225
Financial ratios for SGML — annual report dated 2025-12-31
Total revenue: 80300729.92700729
Gross profit: 13446715.328467153
Operating income: -8876642.335766423
Net income: -36631386.861313865
Capital expenditures: 7945255.474452554
Operating cash flow: 1784671.5328467153
Depreciation & amortization: 7558394.160583941
Net tangible assets: 41335766.42335766
Owner earnings: -37018248.17518248
Return on net tangible assets (%): -89.55500618046972
Buffett classification: The Gruesome
Stock price: 13.19
Shares outstanding: 112064646
Book value: 41335766.423357666
P/B ratio: 35.759169567610805
Market cap (USD): 1478132680.74
Debt to equity: 2.5310612749426094
Current ratio: 0.24566645549730387
Quick ratio: 0.1424196018376723
Interest coverage ratio: -0.536270229748203
COGS to revenue (%): 83.25455404864924
SG&A to revenue (%): 18.1125695378686
Free cash flow (dilution-adjusted): -7630656.9343065685
Buyback yield (%): 0
Retained earnings: -202311678.83211678
Inventory turnover: 4.425065223693111
Receivables turnover: 15.5472018089316
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.03751192684156
FCF margin (%): -9.502599716394576
Revenue growth (%): -24.130474790144554
Rule of 40 score: -33.63307450653913